Company News: Page (1) of 1 - 04/21/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Neurocrine Announces INGREZZA™ Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting

Additional results from largest ever clinical program in tardive dyskinesia to be highlighted as platform and poster presentations (April 21, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Presentors,Business,Business Issues,Presentation,People, Inc.,Disease,Therapy,Surgery,Medication,Science,Lifestyle,Medical,Business,Adults,Other,
Related Sites: Digital Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved